“Aurora kinase/VEGFR2 inhibitor CYC116”的概念、定义、翻译、参考文献-科学参考

An orally bioavailable small molecule multi-kinase inhibitor with antineoplastic activity. Aurora kinase/VEGFR 2 inhibitor CYC116 inhibits Aurora kinases A and B and vascular endothelial growth factor receptor 2 (VEGFR2), resulting in disruption of the cell cycle, rapid cell death, and the inhibition of angiogenesis. Aurora kinases are serine/threonine protein kinases that are only expressed in actively dividing cells and are critical in division or mitosis. VEGFR2 is a receptor tyrosine kinase that appears to account for most of the mitogenic and chemotactic effects of vascular endothelial growth factor (VEGF) on adult endothelial cells.

单词	Aurora kinase/VEGFR2 inhibitor CYC116
释义	Aurora kinase/VEGFR2 inhibitor CYC116 An orally bioavailable small molecule multi-kinase inhibitor with antineoplastic activity. Aurora kinase/VEGFR 2 inhibitor CYC116 inhibits Aurora kinases A and B and vascular endothelial growth factor receptor 2 (VEGFR2), resulting in disruption of the cell cycle, rapid cell death, and the inhibition of angiogenesis. Aurora kinases are serine/threonine protein kinases that are only expressed in actively dividing cells and are critical in division or mitosis. VEGFR2 is a receptor tyrosine kinase that appears to account for most of the mitogenic and chemotactic effects of vascular endothelial growth factor (VEGF) on adult endothelial cells.
随便看	Phase change phase I clinical trial phase I detoxification phase II clinical trial phase II detoxification phase I/II clinical trial phase III clinical trial phase II/III clinical trial phase IV clinical trial Phases of matter PHC Phellodendron amurense bark extract phenelzine sulfate Phenergan phenethyl isothiocyanate phenethyl isothiocyanate phenethyl isothiocyanate-containing watercress juice phenetics phenformin hydrochloride phenobarbital phenobarbital phenocopy phenothiazine phenotype phenoxodiol